Affiliation:
1. Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN
Abstract
Abstract
Survival rates for children with acute lymphoblastic leukemia (ALL) have increased dramatically over the past 4 decades, with 5-year survival rates of > 90% in recent trials. With the increasing number of children and adolescents cured of ALL, identifying and characterizing the occurrence of long-term adverse late effects has become increasingly important. In this young population, successful treatment of ALL is associated with increased risk of adverse outcomes such as late mortality, second neoplasms, chronic health conditions, endocrine dysfunction, and psychological function. Research efforts conducted through large survivor cohorts, such as the Childhood Cancer Survivor Study, are providing new and important insights into the very long-term consequences of ALL therapy, while providing direction for screening recommendations and intervention-based approaches for reducing late morbidity and mortality.
Publisher
American Society of Hematology
Reference36 articles.
1. Howlader
N
Noone
AM
Krapcho
M
SEER Cancer Statistics Review, 1975-2008
Accessed May 4, 2011 (November 2010 SEER data)
Bethesda, MD
National Cancer Institute
Available online at: http://seer.cancer.gov/csr/1975_2008/
2. Estimates of worldwide burden of cancer in 2008: GLOBALCAN 2008;Ferlay;Int J Cancer,2010
3. Outcomes for children and adolescents with cancer: challenges for the twenty-first century;Smith;J Clin Oncol,2010
4. Long-term survivors of childhood cancers in the United States;Mariotto;Cancer Epidemiol Biomarkers Prev,2009
5. Five-year follow-up of “total therapy” of childhood lymphocytic leukemia;Pinkel;JAMA,1971
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献